-
Abbud RA, Finegan CK, Guay LA, Rich EA (1995) Enhanced production of human immunodeficiency virus type 1 by in vitroinfected alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis 172:859–863
doi: 10.1093/infdis/172.3.859
-
Ahn J (2016) Functional organization of human SAMHD1 and mechanisms of HIV-1 restriction. Biol Chem 397:373–379
-
Apolloni A, Meredith LW, Suhrbier A, Kiernan R, Harrich D (2007) The HIV-1 Tat protein stimulates reverse transcription in vitro. Curr HIV Res 5:473–483
-
Apolloni A, Lin MH, Sivakumaran H, Li D, Kershaw MH, Harrich D (2013) A mutant Tat protein provides strong protection from HIV-1 infection in human CD4? T cells. Hum Gene Ther 24:270–282
-
Bauer G, Anderson JS (2014) Gene therapy vectors. In: Gene therapy for HIV. Springer, pp 27–33
-
Braun SE, Taube R, Zhu Q, Wong FE, Murakami A, Kamau E, Dwyer M, Qiu G, Daigle J, Carville A, Johnson RP, Marasco WA (2012) In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat. Hum Gene Ther 23:917–931
doi: 10.1089/hum.2011.184
-
Connor RI, Chen BK, Choe S, Landau NR (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935–944
doi: 10.1006/viro.1995.1016
-
Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ (2004) A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology 330:471–480
doi: 10.1016/j.virol.2004.09.039
-
Forestell SP, Dando JS, Bohnlein E, Rigg RJ (1996) Improved detection of replication-competent retrovirus. J Virol Methods 60:171–178
doi: 10.1016/0166-0934(96)02052-6
-
Guo J, Wang W, Yu D, Wu Y (2011) Spinoculation triggers dynamic actin and cofilin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells. J Virol 85:9824–9833
doi: 10.1128/JVI.05170-11
-
Harrich D, Ulich C, Garcia-Martinez LF, Gaynor RB (1997) Tat is required for efficient HIV-1 reverse transcription. EMBO J 16:1224–1235
doi: 10.1093/emboj/16.6.1224
-
He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR (1995) Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 69:6705–6711
-
Hulme AE, Perez O, Hope TJ (2011) Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc Natl Acad Sci USA 108:9975–9980
doi: 10.1073/pnas.1014522108
-
Jin H, Li D, Sivakumaran H, Lor M, Rustanti L, Cloonan N, Wani S, Harrich D (2016) Shutdown of HIV-1 transcription in T cells by nullbasic, a mutant Tat protein. MBio 7: e00518-16
-
Kamori D, Ueno T (2017) HIV-1 tat and viral latency: what we can learn from naturally occurring sequence variations. Front Microbiol 8:80
-
Kang W, Marasco WA, Tong HI, Byron MM, Wu C, Shi Y, Sun S, Sun Y, Lu Y (2014) Anti-tat Hutat2: Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages. J Neuroinflammation 11:195
doi: 10.1186/s12974-014-0195-2
-
Knight S, Zhang F, Mueller-Kuller U, Bokhoven M, Gupta A, Broughton T, Sha S, Antoniou MN, Brendel C, Grez M, Thrasher AJ, Collins M, Takeuchi Y (2012) Safer, silencingresistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing. J Virol 86:9088–9095
doi: 10.1128/JVI.00485-12
-
Lin MH, Sivakumaran H, Apolloni A, Wei T, Jans DA, Harrich D (2012) Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV Rev trafficking. PLoS ONE 7:e51466
doi: 10.1371/journal.pone.0051466
-
Lin MH, Sivakumaran H, Jones A, Li D, Harper C, Wei T, Jin H, Rustanti L, Meunier FA, Spann K, Harrich D (2014) A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. Retrovirology 11:121
doi: 10.1186/s12977-014-0121-9
-
Lin MH, Apolloni A, Cutillas V, Sivakumaran H, Martin S, Li D, Wei T, Wang R, Jin H, Spann K, Harrich D (2015) A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex. J Virol 89:4827–4836
doi: 10.1128/JVI.03440-14
-
Marasco WA, LaVecchio J, Winkler A (1999) Human anti-HIV-1 Tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS. J Immunol Methods 231:223–238
doi: 10.1016/S0022-1759(99)00159-3
-
Meredith LW, Sivakumaran H, Major L, Suhrbier A, Harrich D (2009) Potent inhibition of HIV-1 replication by a Tat mutant. PLoS ONE 4:e7769
doi: 10.1371/journal.pone.0007769
-
Mhashilkar AM, Bagley J, Chen S, Szilvay A, Helland D, Marasco W (1995a) Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J 14:1542
-
Mhashilkar AM, Bagley J, Chen SY, Szilvay AM, Helland DG, Marasco WA (1995b) Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J 14:1542–1551
-
Mhashilkar AM, LaVecchio J, Eberhardt B, Porter-Brooks J, Boisot S, Dove JH, Pumphrey C, Li X, Weissmahr RN, Ring DB, Ramstedt U, Marasco WA (1999) Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies [see comments]. Hum Gene Ther 10:1453–1467
doi: 10.1089/10430349950017798
-
Naldini L, Verma IM (2000) Lentiviral vectors. Adv Virus Res 55:599–609
doi: 10.1016/S0065-3527(00)55020-9
-
Okitsu T, Kobayashi N, Totsugawa T, Maruyama M, Noguchi H, Watanabe T, Matsumura T, Fujiwara T, Tanaka N (2003) Lentiviral vector mediated gene delivery into non-dividing isolated islet cells. Transplant Proc 35:483
doi: 10.1016/S0041-1345(02)03785-5
-
Pearson L, Garcia J, Wu F, Modesti N, Nelson J, Gaynor R (1990) A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci USA 87:5079–5083
doi: 10.1073/pnas.87.13.5079
-
Robertson-Anderson RM, Wang J, Edgcomb SP, Carmel AB, Williamson JR, Millar DP (2011) Single-molecule studies reveal that DEAD box protein DDX1 promotes oligomerization of HIV-1 Rev on the Rev response element. J Mol Biol 410:959–971
doi: 10.1016/j.jmb.2011.04.026
-
Ruffin N, Brezar V, Ayinde D, Lefebvre C, Schulze Zur Wiesch J, van Lunzen J, Bockhorn M, Schwartz O, Hocini H, Lelievre JD, Banchereau J, Levy Y, Seddiki N (2015) Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1. AIDS 29:519–530
-
Ryan MD, King AM, Thomas GP (1991) Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J Gen Virol 72:2727–2732
doi: 10.1099/0022-1317-72-11-2727
-
Schambach A, Zychlinski D, Ehrnstroem B, Baum C (2013) Biosafety features of lentiviral vectors. Hum Gene Ther 24:132–142
doi: 10.1089/hum.2012.229
-
Taylor MP, Koyuncu OO, Enquist LW (2011) Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol 9:427–439
doi: 10.1038/nrmicro2574
-
Ulich C, Harrich D, Estes P, Gaynor RB (1996) Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins. J Virol 70:4871–4876
-
Varmus HE (1982) Form and function of retroviral proviruses. Science 216:812–820
doi: 10.1126/science.6177038
-
Varmus H (1988) Retroviruses. Science 240:1427–1435
doi: 10.1126/science.3287617
-
Zhou M, Deng L, Kashanchi F, Brady JN, Shatkin AJ, Kumar A (2003) The Tat/TAR-dependent phosphorylation of RNA polymerase Ⅱ C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA. Proc Natl Acad Sci USA 100:12666–12671
doi: 10.1073/pnas.1835726100
-
Zufferey R, Donello JE, Trono D, Hope TJ (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886–2892